Session 1

 

Sunday, September 3
8:00 – 10:00 am

Room 2

 

 

National Cancer Center of China – Chinese Anti Cancer Association

Clinical trials on esophageal cancers

Approaches worldwide (Part 1)

Chairs: Jie He (China) – Long-qi Chen (China)

Panel: Tie-hua Rong (China) – You-lin Qiao (China) – You-sheng Mao (China)
– Arnaud Roth (Switzerland) – Daniela Kandioler (Austria) – Jens Hoppner (Germany)
– Russell E. White (Kenya) – Reza Malekzadeh (Iran) – Salah Al-Batran (Germany)

 

• Genetic landscape of human esophageal squamous cell carcinoma in China. Zhi-hua Liu (China)
• Is the mass screening a possible and best way to reduce the incidence of locally advanced esophageal cancer in China. Wen-qiang Wei (China)
• Current disputed issues in surgical treatment and prospective clinical study projects for esophageal cancer in China. You-sheng Mao (China)
• Comparative results of MI vs robotic esophagectomy. Rubens A. Sallum (Brazil)
• The ICONIC trial (perioperative immune-chemotherapy for esophageal adenocarcinoma).
  Asif Chaudry (UK)